LexDanaLexDanabeta
Inventor

Elisabeth Traiffort

Inventor
Paris, FR

Overview

6→
Patents
2007–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 6 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
A61KPreparations for medical, dental or toiletry purposes29%
C07CAcyclic or carbocyclic compounds12%
C07DHeterocyclic compounds12%
C07KPeptides6%
C12NMicroorganisms or enzymes6%
PatentTitleYear
10,898,495Treatment of demyelinating diseases202110,596,181Treatment of demyelinating diseases20209,073,835'N-acylthiourea and N-acylurea inhibitors of the Hedgehog protein signalling pathway'20158,889,678'Acyl guanidine derivatives modulating the hedgehog protein signaling pathway'20148,703,752'Use of mifepristone and derivatives therefor as Hedgehog protein signaling pathway modulators and applications of same'20147,303,895'Choline transport like (CTL) membrane proteins involved in choline transport'2007

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2007–2015Patents assigned to CENTRE NAT RECH SCIENT (4)· patent assignee history
2007–2021Based in Paris, FR· patent location history
2014–2015Patents assigned to FAURE HÉLÈNE (3)· patent assignee history
2014–2015Patents assigned to RUAT MARTIAL (3)· patent assignee history
2014–2015Patents assigned to TRAIFFORT ELISABETH (3)· patent assignee history
2020–2021Patents assigned to M et P Pharma AG (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CENTRE NAT RECH SCIENT42007–2015
FAURE HÉLÈNE32014–2015
RUAT MARTIAL32014–2015
TRAIFFORT ELISABETHself32014–2015
M et P Pharma AG22020–2021
Locations
LocationPatentsSpan
Paris, FR62007–2021